Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19364967 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: veliparib;   Other: pharmacological study;   Procedure: biopsy

Indicates status has not been verified in more than two years